Why Researchers Choose Cancer Cell for High-Impact Publications
Cancer Cell has established itself as a cornerstone in the field of Biology, particularly for those advancing cancer research. Launched in 2001 by Cell Press, this journal publishes innovative studies that reveal novel mechanisms of cancer development, progression, and treatment. Researchers are drawn to Cancer Cell for its rigorous peer-review process and commitment to high-quality, transformative science. The journal's scope encompasses molecular and cellular aspects of oncology, making it a go-to venue for discoveries in tumor biology, immunotherapy, and precision medicine.
With a focus on interdisciplinary approaches, Cancer Cell bridges Biology with clinical applications, attracting contributions from leading institutions worldwide. Its impact is evident in the caliber of papers it features, often cited in major breakthroughs. For instance, articles on cancer genomics and signaling pathways have influenced therapeutic strategies globally. The journal's editorial team ensures that each publication meets stringent standards, fostering trust among the scientific community.
Publishing in Cancer Cell elevates a researcher's profile, opening doors to collaborations and funding opportunities. The platform's integration with Cell Press resources provides extensive reach through digital archives and multimedia supplements. As cancer remains a pressing global health challenge, Cancer Cell's role in disseminating cutting-edge findings is invaluable. Researchers benefit from its emphasis on mechanistic insights over descriptive studies, encouraging deep, hypothesis-driven work.
To explore academic opportunities in Biology, consider browsing biology faculty jobs or postdoc positions in cancer research. For career planning, check the academic calendar to stay updated on deadlines.
Overview & History
Cancer Cell was founded in 2001 as part of the Cell Press portfolio, aiming to provide a dedicated forum for cancer-specific research within Biology. It emerged during a time when understanding cancer at the molecular level was gaining momentum, filling a gap for specialized publications. Over the years, it has grown into one of the most influential journals, with a consistent output of monthly issues featuring original research, reviews, and perspectives.
The journal's history reflects the evolution of oncology, from early focuses on oncogenes to contemporary emphases on tumor microenvironments and targeted therapies. Key milestones include special issues on immunotherapy and cancer metabolism, which have shaped research agendas. Today, Cancer Cell continues to innovate, incorporating open data policies and rapid publication tracks for urgent findings.
Scope and Disciplines Covered
| Discipline | Description |
|---|---|
| Biology | Core focus on cellular and molecular mechanisms in cancer. |
| Oncology | Clinical and translational studies on tumor progression. |
| Immunology | Research on immune responses to cancer therapies. |
| Genetics | Genomic alterations and hereditary cancer risks. |
Cancer Cell primarily targets Biology but extends to related fields, ensuring comprehensive coverage of cancer science.
Key Journal Metrics
| Metric | Value |
|---|---|
| Impact Factor (2022) | 50.301 |
| 5-Year Impact Factor | 41.576 |
| CiteScore | 58.2 |
| h-Index | 284 |
These metrics highlight Cancer Cell's standing, based on Clarivate Journal Citation Reports and Scopus data.
Indexing and Abstracting
Cancer Cell is indexed in major databases including PubMed/MEDLINE, Scopus, Web of Science, and Embase. This ensures wide accessibility and citation tracking for authors. For open access visibility, it appears in DOAJ-eligible categories, though primarily subscription-based.
Publication Model and Fees
The journal operates a hybrid model, offering subscription access with open access options via the Article Publishing Charge (APC) of approximately $6,200 for gold OA. No fees for standard submissions, but color figures are free. Sherpa/RoMEO rates it as green for self-archiving.
Submission Process and Guidelines
Submissions are handled through the Editorial Manager system on the official site. Guidelines emphasize originality, with pre-submission inquiries encouraged. Review times average 4-6 weeks for initial decisions. Authors must adhere to Cell Press ethics, including data sharing.
Editorial Board Highlights
The board comprises experts from top institutions like MD Anderson and Harvard. Notable members include specialists in cancer genomics and pharmacology, ensuring diverse perspectives. No single Editor-in-Chief; oversight by a managing editor team.
Why Publish in Cancer Cell?
Publishing here offers unparalleled visibility, with articles reaching over a million readers annually. The journal's prestige aids in tenure and grant applications. Its focus on high-impact, mechanistic studies aligns with funding priorities in Biology and oncology.
Comparison with Similar Journals
| Journal | Impact Factor | Publisher | Focus |
|---|---|---|---|
| Cancer Cell | 50.301 | Cell Press | Cancer mechanisms |
| Nature Cancer | 23.178 | Nature | Translational oncology |
| Cancer Discovery | 38.272 | AACR | Discovery research |
| Journal of Clinical Oncology | 45.301 | ASCO | Clinical trials |
Cancer Cell excels in basic science depth compared to more clinical peers.
Researcher Tips for Successful Submission
- Ensure novelty: Highlight mechanistic insights beyond correlations.
- Prepare visuals: High-quality figures are crucial for acceptance.
- Check guidelines: Use the Cancer Cell homepage for templates.
- Seek feedback: Collaborate with board members via networks.
- Integrate data: Comply with open data mandates for reproducibility.
For more resources, visit Rate My Professor or explore tenure-track positions in Biology.
